Integral Health Asset Management, LLC
New York NY · SEC CIK 0001773206
$20.91亿2026Q1 申报市值
90持仓数
44.5%前十大占比 · 第一大 11.7%
28 / 20新建仓 / 清仓
26Q126Q2
前十大持仓 占组合比例
2026Q1 买入最多 按季末市值估算
AZN 新建仓+$4,930.50万
INSM 加仓+$4,088.00万
ROIV 加仓+$3,185.50万
RVMD 加仓+$2,917.50万
BTSG 加仓+$2,130.50万
2026Q1 卖出最多 按季末市值估算
ISRG 减仓-$3,457.43万
AZN 清仓-$3,217.55万
TEVA PHARMACEUTI 清仓-$3,121.00万
PEN 清仓-$3,109.10万
TFX 清仓-$3,051.00万
2026Q1 持仓明细 点表头排序 · 每页 100 行
导出 CSV 🔒| 代码 | 名称 | 市值 ▼ | 占比 | 股数 | 变动股数 | 变动 | 估算买卖额 | 操作 |
|---|---|---|---|---|---|---|---|---|
| — | TERNS PHARMACEUTICALS INC | $0 | 0.00% | 0 | -425,000 | -100.0% | -$1,717.00万 | 清仓 |
| UNH | UNITEDHEALTH GROUP INC | $0 | 0.00% | 0 | — | — | — | 申报中断 |
| RDNT | RADNET INC | $0 | 0.00% | 0 | -200,000 | -100.0% | -$1,427.00万 | 清仓 |
| — | ARCELLX INC | $0 | 0.00% | 0 | -200,000 | -100.0% | -$1,304.00万 | 清仓 |
| EHC | ENCOMPASS HEALTH CORP | $0 | 0.00% | 0 | -100,000 | -100.0% | -$1,061.40万 | 清仓 |
| CRL | CHARLES RIV LABS INTL INC | $0 | 0.00% | 0 | -45,000 | -100.0% | -$897.66万 | 清仓 |
| INSP | INSPIRE MED SYS INC | $0 | 0.00% | 0 | — | — | — | 申报中断 |
| BRKR | BRUKER CORP | $0 | 0.00% | 0 | — | — | — | 申报中断 |
| — | APELLIS PHARMACEUTICALS INC | $0 | 0.00% | 0 | -200,000 | -100.0% | -$502.40万 | 清仓 |
| — | MIND MEDICINE MINDMED INC | $0 | 0.00% | 0 | -350,000 | -100.0% | -$468.65万 | 清仓 |
| EYPT | EYEPOINT INC | $0 | 0.00% | 0 | -200,000 | -100.0% | -$365.40万 | 清仓 |
| GPCR | STRUCTURE THERAPEUTICS INC | $0 | 0.00% | 0 | -50,000 | -100.0% | -$347.75万 | 清仓 |
| — | SIGHT SCIENCES INC | $0 | 0.00% | 0 | -425,000 | -100.0% | -$337.02万 | 清仓 |
| — | GOSSAMER BIO INC | $0 | 0.00% | 0 | -1,000,000 | -100.0% | -$310.00万 | 清仓 |
| OSCR | OSCAR HEALTH INC | $0 | 0.00% | 0 | -200,000 | -100.0% | -$287.40万 | 清仓 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | $0 | 0.00% | 0 | -200,000 | -100.0% | -$156.00万 | 清仓 |